Evidence map›Paper›PMID 42380528›Full record

ArticleJournal of computer-aided molecular design2026

Explainable QSAR models of 5-HT1A receptor ligands using conceptual DFT descriptors and no-code machine learning tools.

Francesca Cáceres, Andrés Halabi-Díaz, Elizabeth Rincón, Eduardo Chamorro

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Francesca CáceresInstituto de Ciencias Químicas, Facultad de Ciencias, Universidad Austral de Chile, Independencia 631, Valdivia, 5090000, Chile.
Andrés Halabi-DíazDepartamento de Ciencias Químicas, Facultad de Ciencias Exactas, Universidad Andrés Bello, Avenida República 275, Santiago, 8370146, Chile. a.halabidiaz@uandresbello.edu.ORCID 0000-0001-6551-3630
Elizabeth RincónInstituto de Ciencias Químicas, Facultad de Ciencias, Universidad Austral de Chile, Independencia 631, Valdivia, 5090000, Chile. elizabethrincon@uach.cl.ORCID 0000-0002-5159-2021
Eduardo ChamorroEscuela de Química y Farmacia, Facultad de Ciencias, Universidad San Sebastián, Av. del Cóndor 720, Campus Ciudad Universitaria, Ciudad Empresarial, Huechuraba, Santiago, 8580704, Chile. eduardo.chamorro@uss.cl.ORCID 0000-0002-9200-9859

Funding

Agencia Nacional de Investigación y Desarrollo Fondecyt Regular 1231018Comisión Nacional de Investigación Científica y Tecnológica PhD scholarship No. 21221699
6 · The paper itself

Abstract

Quantitative structure-activity relationship (QSAR) modeling is a central component of molecular informatics and ligand-based drug discovery, enabling the analysis and interpretation of structure-activity relationships from molecular descriptors. In this study, mechanistically interpretable binary QSAR models were developed to classify the activity of 89 serotonin 5-HT1A receptor ligands by integrating Conceptual Density Functional Theory (CDFT) descriptors with no-code machine learning workflows. Neutral and protonated molecular forms were considered under both vacuum and aqueous conditions, and electronic reactivity indices (η, μ, ω, and ΔN

Indexed as

Machine LearningQuantitative Structure-Activity RelationshipReceptor, Serotonin, 5-HT1AAlgorithmsDensity Functional TheoryDrug DiscoveryHumansLigandsModels, MolecularLigandsReceptor, Serotonin, 5-HT1AConceptual density functional theoryLigand-based modelingMechanistic interpretationMolecular informaticsQuantitative structure–activity relationships (QSAR)Serotonin 5-HT1A receptor

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.